Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2024-11-18 Major Shareholding Noti…
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in share ownership (specifically, the conversion of preferred shares to common shares and the termination of a joint voting agreement) by 'Kiwoom-Yeollim Healthcare Fund 1' regarding the company 'Quratis'. This type of filing is used to notify the market and regulators of significant changes in shareholding thresholds (typically 5% or more). In the provided classification schema, this falls under 'Major Shareholding Notification'.
2024-11-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, specifically the exclusion of a special related party (Kiwoom-Yulrim Healthcare Investment Fund No. 1) due to the termination of a voting rights agreement. This falls under the category of Major Shareholding Notification.
2024-11-18 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase/private placement) by Quratis. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-11-15 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 3rd quarter of 2024, issued by Quratis Inc. It contains detailed company information, business operations, and financial data structure typical of a formal quarterly filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (청소년 및 성인을 대상으로 하는 QTP101(결핵예방백신) 제 2b/3상 임상시험계획서(IND) 변경 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure about a clinical trial plan (IND) for a tuberculosis vaccine (QTP101). It details changes to the clinical trial institutions and countries involved. Since it is a formal regulatory announcement of a material business event (clinical trial update) and does not fit into specific categories like earnings releases or annual reports, it is classified as a Regulatory Filing (RNS).
2024-11-11 Korean
기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Quratis regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-11-11 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.